HCG-LH/CG Receptor Binding and Activation
HCG-LH/CG Receptor Binding and Activation
批准号:
7222641
负责人:
J DAVID PUETT
金额:
$47.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 2010-04-30
关键词:
AddressAffinityAgonistArchitectureBindingBiologicalC-terminalCell membraneCellsChorionic GonadotropinClassCompatibleComplexCouplingDevelopmentDiseaseEngineeringEpitopesEquilibriumFaceFamilyFemaleFutureG-Protein-Coupled ReceptorsGTP-Binding ProteinsGlycoproteinsGoalsGonadotropinsHelix (Snails)Homology ModelingHormone ReceptorHormonesHumanHuman EngineeringInvestigationLH ReceptorsLaboratory ResearchLeadLeucine-Rich RepeatLigand BindingLigandsLuteinizing HormoneMediatingMethodologyModelingMolecularMolecular ConformationMutationNatureNumbersOrphanOvarian Hyperstimulation SyndromePrecocious PubertyProcessPropertyProtein EngineeringQualifyingRangeReagentReceptor ActivationReproductive EndocrinologyResearchRhodopsinSeriesShapesSignal PathwaySignal TransductionSiteSolutionsStructureStructure-Activity RelationshipTechniquesTestinganalogbaseconceptdesignear helixextracellularinhibitor/antagonistmalemembermimeticsmutantreceptorreceptor bindingreceptor structure functionreproductiveresponsesmall moleculesuccess
中文摘要
描述(由申请人提供):该项目的长期目标是在分子水平上描述:(a)负责异二聚体糖蛋白激素,人绒毛膜促性腺激素(hCG)与lutropin/绒毛膜促性腺激素受体(LHR)特异性高亲和力结合的结构决定因素,LHR是G蛋白偶联受体超家族的成员;(b)配体依赖性和非配体依赖性LH受体激活机制;(c)受体激活Gs启动细胞内信号通路的机制。最近的几项进展提供了希望,说明生殖内分泌学中的这些基本问题是可以实现的。基于激素和受体构象可塑性的新兴概念,本项目提出了两个具体目标。1. hCG和LHR结合决定因素的描述:这一目标代表了正在进行的研究的继续,以阐明野生型和工程hCG类似物与受体外结构域之间的结构和接触位点,并对所提出的外结构域模型进行了严格的测试,该模型假定由于一系列富含亮氨酸的重复而具有尖端形状。2. 受体激活和Gs偶联机制:本研究旨在探讨野生型和工程型细胞外hcg -外结构域复合物激活受体跨膜部分的机制,导致LHR激活的跨膜螺旋和细胞内环的结构变化,以及Gs激活所需的LHR决定因素的阐明。蛋白质工程、生物物理研究和细胞/分子生物学技术的结合将被用来解决这些目标。该项目的成功将大大提高我们对男性和女性生殖内分泌基本机制的认识,并为LHR激动剂和拮抗剂的合理设计提供新的信息。
英文摘要
DESCRIPTION (provided by applicant): The long-range goals of this project are delineation, at the molecular level, of: (a) the structural determinants responsible for specific, high-affinity binding of the heterodimeric glycoprotein hormone, human choriogonadotroin (hCG), to the lutropin/choriogonadotropin receptor (LHR), a member of the G protein-coupled receptor superfamily; (b) the mechanisms of ligand-dependent and ligand-independent LH receptor activation; and (c) the mechanism by which the receptor activates Gs to initiate intracellular signaling pathways. Several recent advances offer promise that elucidation of these fundamental issues in reproductive endocrinology are realistically achievable. Two specific aims, based upon emerging concepts of conformational plasticities of both the hormone and receptor, are proposed for this project. 1. Delineation of hCG and LHR binding determinants: This aim represents a continuation of ongoing studies to elucidate structures of and contact sites between wild type and engineered analogs of hCG and the receptor ectodomain, with a rigorous test of the proposed model of the ectodomain that is postulated to have a cusp shape due to a series of leucine-rich repeats. 2. Mechanisms of receptor activation and Gs coupling: This aim addresses the mechanisms by which wild type and engineered extracellular hCG-ectodomain complexes activate the transmembrane portion of the receptor, the resulting structural changes of the transmembrane helices and intracellular loops responsible for LHR activation, and elucidation of determinants in LHR required for Gs activation. A combination of protein engineering, biophysical investigations, and cell/molecular biological techniques will be utilized to address these aims. Success of this project will greatly enhance our understanding of fundamental mechanisms in male and female reproductive endocrinology and provide new information to assist rational design of LHR agonists and antagonists.
期刊论文(74)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
同源配体-受体相互作用的特异性:人绒毛膜促性腺激素和人黄体生成素、促甲状腺激素和卵泡刺激素七螺旋受体的融合蛋白。
DOI:
10.1210/en.2002-220829
发表时间:
2003
期刊:
Endocrinology.
影响因子:
--
作者:
[Schubert,RebeccaL, Narayan,Prema, Puett,David]
通讯作者:
Puett,David
Tightly regulated and inducible expression of a yoked hormone-receptor complex in HEK 293 cells.
HEK 293 细胞中轭状激素受体复合物的严格调控和诱导表达。
DOI:
10.1677/jme.0.0320247
发表时间:
2004
期刊:
Journal of molecular endocrinology
影响因子:
3.5
作者:
[Meehan,TP, Puett,D, Narayan,P]
通讯作者:
Narayan,P
Binding to tubulin of the colchicine analog 2-methoxy-5-(2', 3', 4'-trimethoxyphenyl)tropone. Thermodynamic and kinetic aspects.
与秋水仙碱类似物 2-甲氧基-5-(2, 3, 4-三甲氧基苯基)托酮的微管蛋白结合。
DOI:
--
发表时间:
1984
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Bane,S, Puett,D, Macdonald,TL, WilliamsJr,RC]
通讯作者:
WilliamsJr,RC
Divergent effects of phenothiazines on Leydig tumor cell steroidogenesis and adenylate cyclase activity.
吩噻嗪对 Leydig 肿瘤细胞类固醇生成和腺苷酸环化酶活性的不同影响。
DOI:
10.1016/0022-4731(83)90404-1
发表时间:
1983
期刊:
Journal of steroid biochemistry
影响因子:
--
作者:
[Melner,MH, Zimniski,SJ, Puett,D]
通讯作者:
Puett,D
Protein engineering of a novel constitutively active hormone-receptor complex.
新型组成型活性激素受体复合物的蛋白质工程。
DOI:
10.1074/jbc.271.49.31638
发表时间:
1996
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Wu,C, Narayan,P, Puett,D]
通讯作者:
Puett,D
共 60 条
Binding Determinants of Glycoprotein Hormone Receptors
-
批准号:6855902
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2005
-
负责人:J DAVID PUETT
-
依托单位:
Binding Determinants of Glycoprotein Hormone Receptors
-
批准号:7171597
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2005
-
负责人:J DAVID PUETT
-
依托单位:
Binding Determinants of Glycoprotein Hormone Receptors
-
批准号:7332216
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2005
-
负责人:J DAVID PUETT
-
依托单位:
Binding Determinants of Glycoprotein Hormone Receptors
-
批准号:6995214
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2005
-
负责人:J DAVID PUETT
-
依托单位:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
-
批准号:3288115
-
项目类别:
-
资助金额:$22.05万
-
财政年份:1985
-
负责人:J DAVID PUETT
-
依托单位:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
-
批准号:3288111
-
项目类别:
-
资助金额:$22.21万
-
财政年份:1985
-
负责人:J DAVID PUETT
-
依托单位:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
-
批准号:3288116
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1985
-
负责人:J DAVID PUETT
-
依托单位:
CONFORMATIONS AND MECHANISMS OF PITUITARY HORMONES
-
批准号:3153033
-
项目类别:
-
资助金额:$29.32万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG LH/CG RECEPTOR BINDING AND ACTIVATION
-
批准号:2905309
-
项目类别:
-
资助金额:$35.3万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG STRUCTURE-FUNCTION RELATIONSHIPS
-
批准号:3232388
-
项目类别:
-
资助金额:$3.03万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG-LH/CG Receptor Binding and Activation
-
批准号:6613530
-
项目类别:
-
资助金额:$44.97万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
CONFORMATIONS AND MECHANISMS OF PITUITARY HORMONES
-
批准号:3232390
-
项目类别:
-
资助金额:$30.52万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG LH/CG RECEPTOR BINDING AND ACTIVATION
-
批准号:6517070
-
项目类别:
-
资助金额:$38.53万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG LH/CG RECEPTOR BINDING AND ACTIVATION
-
批准号:2462991
-
项目类别:
-
资助金额:$34.3万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
CONFORMATIONS AND MECHANISMS OF PITUITARY HORMONES
-
批准号:3232391
-
项目类别:
-
资助金额:$32.69万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
CONFORMATIONS AND MECHANISMS OF PITUITARY HORMONES
-
批准号:3232389
-
项目类别:
-
资助金额:$28.67万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG STRUCTURE-FUNCTION RELATIONSHIPS
-
批准号:3232385
-
项目类别:
-
资助金额:$1.23万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG STRUCTURE-FUNCTION RELATIONSHIPS
-
批准号:3232395
-
项目类别:
-
资助金额:$9.1万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG-LH/CG Receptor Binding and Activation
-
批准号:7052879
-
项目类别:
-
资助金额:$47.3万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
HCG LH/CG RECEPTOR BINDING AND ACTIVATION
-
批准号:6380493
-
项目类别:
-
资助金额:$37.43万
-
财政年份:1983
-
负责人:J DAVID PUETT
-
依托单位:
海外基金